Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
See detailLa prevención en América Latina de la doble imposición internacional en la perspectiva de la redacción de un tratado modelado
Richelle, Isabelle ULg

in Mazz, Addy; Pistone, Pasquale (Eds.) Reflexiones en torno a un Modelo Latinoamericano de Convenio de Doble Imposición (2011)

Detailed reference viewed: 7 (1 ULg)
Full Text
See detailPrévenir et traiter les troubles d'origine nutritionnelle chez le chiot
Diez, Marianne ULg

in Formavet (Ed.) Congrès SAVAB 2011 "Les chiots et nous" (2011, October 29)

Diapositives de la conférence - accès restreint (étudiants et collègues uniquement)

Detailed reference viewed: 23 (3 ULg)
Full Text
See detailPrévenir l'herpès néonatal
Nikkels, Arjen ULg

in Virologics (1995), 5

Detailed reference viewed: 2 (0 ULg)
Full Text
Peer Reviewed
See detailPrévenir la myopathie atypique du cheval au pré par la gestion raisonnée des pâtures et des chevaux établie sur base de l'identification des facteurs de risques de la maladie
Votion, Dominique ULg; Delguste, Catherine ULg; Amory, Hélène ULg et al

in 33ème Journée de la Recherche Equine (2007, March 08)

La myopathie atypique (MA) des équidés est un syndrome de destruction musculaire massive et sévère affectant des chevaux séjournant en pâture. Cette myopathie, généralement fatale endéans les 72 heures ... [more ▼]

La myopathie atypique (MA) des équidés est un syndrome de destruction musculaire massive et sévère affectant des chevaux séjournant en pâture. Cette myopathie, généralement fatale endéans les 72 heures, est rencontrée en France de manière significative et récurrente depuis l’automne 2002. La Belgique a reconnu ses premiers cas de MA au cours de l’automne 2000. Grâce à la collecte systématique des données épidémiologiques et cliniques des cas belges confirmés par analyse histologique de muscles prélevés post mortem, il a été possible de définir les facteurs de risques contribuant à l’émergence de la maladie dans une prairie et/ ou au sein d’un élevage. A partir de ces facteurs de risques identifiés, des mesures de prévention de la MA sont proposées et discutées. [less ▲]

Detailed reference viewed: 102 (6 ULg)
Full Text
See detailPrévenir le mal
Strivay, Lucienne ULg

in Lempereur, Françoise; Neuberg, André (Eds.) Guérisseurs d'hier et d'aujourd'hui (2003)

Detailed reference viewed: 27 (1 ULg)
Full Text
See detailPrévenir les mammites bovines - Techniques et outils en 2012
Theron, Léonard ULg; Hanzen, Christian ULg

Conference given outside the academic context (2012)

Detailed reference viewed: 56 (6 ULg)
Peer Reviewed
See detailPréventeurs de tous les pays, unissez-vous
Lemaître, André ULg

in Revue de Droit Pénal et de Criminologie (1996), 7-8

Detailed reference viewed: 4 (2 ULg)
Full Text
Peer Reviewed
See detailPreventie van postmenopauzale osteoporose
Reginster, Jean-Yves ULg; Halkin, V

in De agenda Gynaecologie (2000), 19

Detailed reference viewed: 2 (1 ULg)
Full Text
See detailPreventing Violence in sport: A guidebook for cities
Comeron, Manuel ULg; Bures, Radim; Johnston, Elizabeth

Report (2012)

Large sports events, in football in particular, have become global and attract increasingly large audiences on site and through media and broadcasting. Their impact on public life is growing accordingly ... [more ▼]

Large sports events, in football in particular, have become global and attract increasingly large audiences on site and through media and broadcasting. Their impact on public life is growing accordingly, above all in host cities, since they are on the front line when it comes to ensure safety and security in and around stadiums, for spectators and local inhabitants. The objective of this publication is to support cities in the prevention of sport-related violence through the promotion of a multisectoral and comprehensive approach. [less ▲]

Detailed reference viewed: 72 (10 ULg)
Full Text
Peer Reviewed
See detailPreventing, delaying, or masking type 2 diabetes with metformin in the diabetes prevention program?
Scheen, André ULg

in Diabetes Care (2003), 26(9), 27012701-3

Detailed reference viewed: 8 (0 ULg)
Full Text
Peer Reviewed
See detailPrévention - normes de construction - Introduction à l'Eurocode 8 et à son annexe nationale belge
Plumier, André ULg; Degée, Hervé ULg

in Actes du Colloque "Evaluation et prévention du risque sismique en Région Wallonne" (2006)

Detailed reference viewed: 195 (4 ULg)
Full Text
See detailPrevention and management of violence in Belgian psychiatric institutions: do current practices respect international guidelines?
Lardenois, Miguel; Duquesne, Patricia; Gillain, Nicolas ULg et al

Poster (2007, October)

Detailed reference viewed: 26 (7 ULg)
See detailPrevention and Mitigation of Societal Disruption
Brunet, Sébastien ULg

Report (2003)

Detailed reference viewed: 5 (1 ULg)
Full Text
Peer Reviewed
See detailPrevention and treatment of major blood loss
Detry, Olivier ULg; De Roover, Arnaud ULg; Honore, Pierre ULg

in New England Journal of Medicine [=NEJM] (2007), 357(12), 1261-1261

Detailed reference viewed: 53 (14 ULg)
See detailPrevention and treatment of postmenopausal osteoporosis.
Neuprez, Audrey ULg; Reginster, Jean-Yves ULg

in Rizzoli, R. (Ed.) Atlas of postmenopausal osteoporosis (2010)

Detailed reference viewed: 26 (6 ULg)
Full Text
Peer Reviewed
See detailPrevention and treatment of postmenopausal osteoporosis. National consensus of the Belgian Bone Club"
Kaufman, JM; Devogelaer, JP; Raeman, F et al

in Clinical Rheumatology (1997), 16(4), 343-345

Detailed reference viewed: 12 (4 ULg)
Full Text
Peer Reviewed
See detailPrevention cardio-vasculaire chez le patient diabetique de type 2.
Paquot, Nicolas ULg; Scheen, André ULg

in Revue Médicale de Liège (2003), 58(5), 271-4

It is estimated that 80% of individuals with type 2 diabetes die of cardiovascular diseases. Several factors account for the accelerated atherosclerosis present in diabetic patients. These include ... [more ▼]

It is estimated that 80% of individuals with type 2 diabetes die of cardiovascular diseases. Several factors account for the accelerated atherosclerosis present in diabetic patients. These include hyperglycaemia, dyslipidaemia, hypertension and prothrombotic state. Hypoglycaemic agents, statin or fibrates that improve dyslipidaemia, anti-hypertensive agents, aspirin and healthy lifestyle can modify these factors and have been shown to reduce morbidity and mortality caused by coronary heart disease in diabetic patients. It was recently demonstrated that a multifactorial intervention on modifiable risk factors of cardiovascular disease in type 2 diabetic patients dramatically reduces the incidence of cardiovascular events. Thus, an intensified intervention aimed at multiple risk factors should be recommended in patients with type 2 diabetes. [less ▲]

Detailed reference viewed: 706 (4 ULg)
Full Text
Peer Reviewed
See detailPrevention cardio-vasculaire par les statines: faut-il encore doser le cholesterol?
Scheen, André ULg; Kulbertus, Henri ULg

in Revue Médicale de Liège (2003), 58(4), 191-7

Statins, the most popular lipid-lowering agents, have proven their efficacy in preventing cardiovascular events in subjects with lower and lower initial plasma cholesterol levels. Besides, the protective ... [more ▼]

Statins, the most popular lipid-lowering agents, have proven their efficacy in preventing cardiovascular events in subjects with lower and lower initial plasma cholesterol levels. Besides, the protective effect does not seem to be directly related neither to the degree of the cholesterol reduction nor to the final level of plasma cholesterol level reached under treatment. Such observations suggest that statins may exert vascular protective effects, at least in part, independently of their specific cholesterol-lowering effect (so-called pleiotropic effects). The present paper will discuss the arguments pro and contra the dosage of cholesterolaemia before initiating a therapy with statin and during treatment follow up, both in subjects with previous cardiovascular events (secondary prevention) and in subjects with a high cardiovascular absolute risk but without previous clinical expression of atherosclerosis (primary prevention). [less ▲]

Detailed reference viewed: 404 (0 ULg)